Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PARADE
NCT07101445Phase 4Recruiting
- Sponsor
- Emory University
- Start
- Sep 2025
- Primary completion
- Dec 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of methylprednisolone injection in allergic reaction, sponsored by Emory University. Started Sep 2025; status: recruiting.
02
Drugs
methylprednisolone injection
03
Conditions
allergic reaction
Beyond the preview
Go deeper on NCT07101445.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07101445.